Reporting Owner Activity for John P. Schmid

Form 3/4/5 issuer links and transaction evidence for this reporting owner.

Linked issuers

Largest position

ANAPTYSBIO, INC

Disclosed value

$2.54M

Transaction activity

Available

Forms 3/4/5 ownership snapshot: Forms 3/4/5 show reporting-owner positions and transactions. They are useful ownership-context signals, not a complete public-float ownership table.
Estimated Forms 3/4/5 ownership value
$2.54M
Estimated from parsed Forms 3/4/5 when filings include enough holding data.
Issuers linked to this owner
8
Distinct issuers connected to this reporting owner in parsed SEC filings.
Largest linked issuer position
ANAPTYSBIO, INC (ANAB)
$1.91M estimated from parsed reporting-owner filings.
Latest parsed reporting-owner filing
14 May 2026
Most recent reporting-owner filing date in the parsed SEC record.
ANAPTYSBIO, INC (ANAB)
Estimated value: $1.91M · 12-month value change: -$1.16M · Role: Director
BridgeBio Oncology Therapeutics, Inc. (BBOT)
Estimated value: $321.5K · Role: Former Director
Xeris Biopharma Holdings, Inc. (XERS)
Estimated value: $310.9K · Role: Director
+5 more
Additional issuer positions are listed below.
How to read Forms 3/4/5 positions
Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
Use this as reporting-owner context, not as a complete capitalization table.
Location: San Diego, CA
Latest reporting-owner signature: /s/ Ajim Tamboli, Attorney-in-Fact
SEC filing history: Open SEC filing history

Follow Filing Activity

Follow John P. Schmid and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here